2017
Genetic Evaluation for Women at Increased Risk
Brierley K, Healy C, Hofstatter E. Genetic Evaluation for Women at Increased Risk. 2017, 15-30. DOI: 10.1007/978-3-319-59198-8_2.Peer-Reviewed Original ResearchOvarian cancerFamily historyHereditary breastUS Preventative Services Task ForceModerate-penetrance genesHereditary cancer predispositionHealth care providersManagement of individualsBRCA mutationsPretest counselingCare providersGenetic testing optionsMultidisciplinary teamRisk assessmentInformed consentPatientsCancerTesting optionsGenetic counseling processFurther risk assessmentCancer predispositionCancer geneticsBreastTask ForceProviders
2013
Rothman index as a predictor for type of discharge and readmission rates in a cancer hospital: The Yale experience.
Morgensztern D, Xia B, Kournioti C, Hofstatter E, Raucci M, Keyes A, Morrione A, Blasiak E, Rosenberg E, Rimar J, Rothman M, Lilenbaum R. Rothman index as a predictor for type of discharge and readmission rates in a cancer hospital: The Yale experience. Journal Of Clinical Oncology 2013, 31: 6635-6635. DOI: 10.1200/jco.2013.31.15_suppl.6635.Peer-Reviewed Original ResearchTime of dischargeRothman IndexElectronic medical recordsCancer HospitalRA ratesEvaluation of inpatientsSmilow Cancer HospitalDC typesPredictors of dischargeRate of readmissionHospital electronic medical recordsLength of stayHealth care providersRI meanOncology inpatientsReadmission ratesMedian ageProspective studyNursing assessmentCommon tumorsElective admissionsMedical recordsDisposition planningCare providersReadmission